A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation
for Antibody Mediated Rejection of Lung Transplant
2 locations incl. St Louis
Sponsor: Washington University School of Medicine
Sex: All·Age: 18+
Code: NCT06990711·Phase 1·Recruiting·Listed May 2025